Report #2895859

Received May 8, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 73 yrs
State: TX
Recovered: Unknown
Vaccinated: Apr 13, 2026
Onset: Apr 13, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	3	NT357	—

Symptoms (1)

Extra dose administered

Symptom narrative

3rd dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 73-year-old male patient who received Herpes zoster (Shingrix) (batch number NT357, expiry date 12-MAY-2028) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 27-JUN-2024) and Shingrix (received 2nd dose on 30-AUG-2024). On 13-APR-2026, the patient received the 3rd dose of Shingrix. On 13-APR-2026, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: 3rd dose administered). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 30-APR-2026 The vaccine administration facility was the same as primary reporter.